Comparative Effects of Nerve Gliding Exercises and Conventional Grip Strength Exercises in Batters.

January 18, 2025 updated by: Sehat Medical Complex

Comparative Effects of Nerve Gliding Exercises and Conventional Grip Strength Exercises on Grip Strength, Range of Motion and Performance of Cricket Batters

Cricket is transformed over the years and dynamic of batting has changed. Gone are the days, when batters used to play the game with defensive mindset. Maintaining higher striker rate and arsenal of power hitting is the epitome of stroke play in limited overs cricket.This study will compare the effects of the nerve gliding exercises and conventional grip strength exercises on handgrip strength, range of motion and performance of cricket batters.

It will be a randomized clinical trial where non-probability convenience sampling will be used to recruit participants aged 18 to 35 years from various cricket academies in Lahore.

Study Overview

Detailed Description

Cricket is transformed over the years and dynamic of batting has changed. Gone are the days, when batters used to play the game with defensive mindset. Maintaining higher striker rate and arsenal of power hitting is the epitome of stroke play in limited overs cricket. After modernization of the game, several exercises are adapted to enhance the hitting capability of batsmen with conventional grip strength training but the effectiveness of nerve gliding exercises on handgrip strength is not utilized in cricketing population effectively as compared to tennis and squash players, where it improves the efficiency of wrist mobility in efficient stroke play. This study will compare the effects of the nerve gliding exercises and conventional grip strength exercises on handgrip strength, range of motion and performance of cricket batters. It will be a randomized clinical trial where non-probability convenience sampling will be used to recruit participants aged 18 to 35 years from various cricket academies in Lahore.

Participants will be randomized through lottery method and allocated into two groups. Group A (n=20) participants will receive nerve gliding exercises intervention, while Group B (n=20) will receive conventional grip strength exercises intervention. The Adjustable Hand Dynamometer for Grip Strength, Goniometer for Range of motion while Batting Tee Test for performance will be outcome measure tools. Data will be analyzed by SPSS version 26. The normality of the data will be conducted through the Shapiro-Wilk test; for between-group analysis, an independent t-test or Mann-Whitney will be conducted. Similarly, a paired t-test or Wilcoxon Rank test will be conducted for within-group analysis.

Study Type

Interventional

Enrollment (Estimated)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Punjab
      • Lahore, Punjab, Pakistan, 54000
        • Recruiting
        • Riphah International University
        • Contact:
        • Contact:
          • Suleman Ashiq Dr., DPT, MS-SPT

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age between 18 to 35 years

    • Batsmen
    • Doing net practices more than 4 days per week for at least 3 months.
    • Right hand grip strength (men) 42.9-46.4, Left hand grip strength (men) 42.042.2.

Exclusion Criteria:

  • Non-Athletic Population

    • Upper extremity peripheral neuropathies.
    • Tennis/Golfer epicondylitis. Cervical disc herniation.
    • Overuse injuries of the shoulder joint that may affect handgrip strength.
    • Having any neurological or orthopaedical problem related to upper extremity.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nerve Gilding Exercises

This group will receive 25-minute session of nerve gliding exercises per session five days a week for six weeks. It will include: Warm-Up (5 minutes)

Neural Gliding of the upper quadrant:

Median nerve glide (5 minutes) Ulnar nerve glide (5 minutes) Radial nerve glide (5 minutes) Cool Down (5 minutes)

Active Comparator: Conventional Grip Strength Exercises

This group's participants will also receive a 25 -minute session five days per week (for six weeks). Warm-Up (5 minutes) Conventional Grip Strength Exercises (15 Minutes)

  • Tendon gliding sequence of exercises for hand
  • Squeezing a rubber ball or stress ball
  • Dead Hang Cool Down (5 Minutes)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Handgrip Strength Test using Dynamometer
Time Frame: 6 weeks
A handgrip dynamometer is a device used to measure the strength of a person's hand grip, providing an objective assessment of their hand and forearm muscle strength.
6 weeks
Universal Goniometer
Time Frame: 6 weeks
A universal goniometer is a medical instrument used to measure the range of motion (ROM) in joints, particularly in the hands and fingers. It consists of a protractor-like device with two arms and a fulcrum, allowing healthcare professionals to quantify the angles formed by joints during movement. Hand goniometer has demonstrated validity as a measure of functional ROM.
6 weeks
Batting Tee Test
Time Frame: 6 weeks
A batting tee test is a common method used in baseball or softball to assess a player's hitting skills and technique. This test involves the use of a stationary tee, placed at an appropriate height, from which the player hits the ball.
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Suleman Ashiq Dr., DPT, MS-SPT, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2024

Primary Completion (Estimated)

May 25, 2025

Study Completion (Estimated)

May 30, 2025

Study Registration Dates

First Submitted

October 27, 2024

First Submitted That Met QC Criteria

November 13, 2024

First Posted (Actual)

November 14, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 18, 2025

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • REC/RCR & AHS/24/0422

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe